Author

Ming Yi

Frederick National Laboratory for Cancer ResearchORCID 0000-0001-5243-6613Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ming Yi1 paper · University of Electronic Science and Technology of China

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Douglas R. LowyiD· 1 shared Haibin LiuiD· 1 shared Lulu YuiD· 1 shared Maggie CamiD· 1 shared Peter F. JohnsoniD· 1 shared Thomas Joshua MeyeriD· 1 shared Vladimır MajerčiakiD· 1 shared Zhi‐Ming ZhengiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Douglas R. LowyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyeLifePeer-reviewedNov 28, 2024

The lnc-FANCI-2 intrinsically restricts RAS signaling in HPV16-infected cervical cancer

Haibin Liu, Lulu Yu, Vladimır Majerčiak…·Zhi‐Ming Zheng

This study identifies lnc-FANCI-2 as a regulator of RAS signaling in HPV16-infected cervical cancer, showing its role in lesion progression and patient survival.

3 citations

humanproteomics

𝕏 PostBluesky